# Assessing Effectiveness of Adalimumab for Treating Ulcerative Colitis in Real Life Conditions

> **NCT02738125** · — · COMPLETED · sponsor: **AbbVie** · enrollment: 265 (actual)

## Conditions studied

- Ulcerative Colitis (UC)

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02738125
- **Lead sponsor:** AbbVie
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-04-29
- **Primary completion:** 2023-12-15
- **Final completion:** 2023-12-15
- **Target enrollment:** 265 (ACTUAL)
- **Last updated:** 2024-12-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02738125

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02738125, "Assessing Effectiveness of Adalimumab for Treating Ulcerative Colitis in Real Life Conditions". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT02738125. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*